Citi analyst Jason Bazinet raised his price target for Meredith shares to $61 from $56 and keeps a Buy rating on the name. Management continues to expect $1B in EBITDA in fiscal 2020, but most investors do not believe this can be achieved, Bazinet tells investors in a research note titled "You Don't Need to Believe in $1B of FY20 EBITDA to be Bullish." Short interest in the name is near record levels and sell-side consensus expectations call for just $746M of fiscal 2020 EBITDA, the analyst points out. Bazinet "only" expects $777M in in 2020 EBITDA. However, the analyst believes that even with his "more muted" EBITDA estimates, Meredith's equity could reach $61 per share. And, if Meredith achieves its $1B target, the equity could reach $99 per share, Bazinet writes. The stock closed yesterday up 50c to $51.40.